Grant: Team Grant: E-Rare Joint Transnational Call
McGill University
$150,000.00
INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis
EF 2018-19
Résumé
ALS is the most common motor neuron disease. It is characterized by the death of motor neurons (MNs) in the brain and spinal cord. The disease starts in adult life and causes a progressive paralysis that is typically fatal within a few years, usually due to respiratory failure. The number of ALS cases worldwide is predicted to increase to nearly 400,000 in 2040, largely due to the aging population. Yet, no effective therapy is currently available for ALS. The current lack of treatments that can halt or reverse ALS highlights the need for disease relevant human cell-based experimental model systems to study the pathophysiological mechanisms underlying the degeneration of motor circuits in ALS. In this regard, the present application seeks to develop and validate previously unavailable experimental model systems to study ALS pathophysiology based on both neuronal and glial cells derived from induced pluripotent stem cells (iPSCs) obtained from ALS patients or non-ALS controls. This project involves academic partners with solid expertise in ALS, iPSC technology and high-throughput ("omics") approaches. This unique combined international discovery effort will allow the assessment of the roles played by energy metabolism and immune pathways in ALS pathogenesis and their potential as therapeutic targets. Achieving these objectives will lead to new advances into the study of ALS pathophysiology and will contribute to the emerging field of ALS disease modeling based on disease-relevant human iPSC-derived cells. These are both important and timely goals of ALS research.
Programme
Team Grant: E-Rare Joint Transnational Call
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
387428
Name
Stifani Stefano
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
German Federal Ministry of Research, Technology and Space (Berlin); Fonds de recherche du Québec - Santé (FRQS); Fonds de recherche du Québec - Santé (FRQS); The Netherlands Organization for Health Research and Development (ZonMw); Research Foundation - Flanders (Belgium); Ministero della Salute (Italy)
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Team Grant: E-Rare Joint Transnational Call
Keyworddelim
Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Neurodegenerative Disease
Abstract
ALS is the most common motor neuron disease. It is characterized by the death of motor neurons (MNs) in the brain and spinal cord. The disease starts in adult life and causes a progressive paralysis that is typically fatal within a few years, usually due to respiratory failure. The number of ALS cases worldwide is predicted to increase to nearly 400,000 in 2040, largely due to the aging population. Yet, no effective therapy is currently available for ALS. The current lack of treatments that can halt or reverse ALS highlights the need for disease relevant human cell-based experimental model systems to study the pathophysiological mechanisms underlying the degeneration of motor circuits in ALS. In this regard, the present application seeks to develop and validate previously unavailable experimental model systems to study ALS pathophysiology based on both neuronal and glial cells derived from induced pluripotent stem cells (iPSCs) obtained from ALS patients or non-ALS controls. This project involves academic partners with solid expertise in ALS, iPSC technology and high-throughput ("omics") approaches. This unique combined international discovery effort will allow the assessment of the roles played by energy metabolism and immune pathways in ALS pathogenesis and their potential as therapeutic targets. Achieving these objectives will lead to new advances into the study of ALS pathophysiology and will contribute to the emerging field of ALS disease modeling based on disease-relevant human iPSC-derived cells. These are both important and timely goals of ALS research.
Competitiondate
201806
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stifani, Stefano
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $150,000~ $0~